Cyclin E is a target of WT1 transcriptional repression

David M. Loeb, Dorian Korz, Michael Katsnelson, Emily A. Burwell, Alan D. Friedman, Saraswati Sukumar

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

WT1 was originally identified as a Wilms' tumor suppressor gene, but it may have oncogenic potential in leukemia and in some solid tumors. WT1 is a transcription factor that has been implicated in the regulation of target genes related to apoptosis, genitourinary differentiation, and cell cycle progression. Because induction of WT1 leads indirectly to increased p21 expression in osteosarcoma cells, we investigated the possibility that other genes involved in the G1/S phase transition might also be WT1 targets. Cyclin E plays a crucial role in the cell cycle by activating cyclin-dependent kinase 2, which phosphorylates Rb, leading to progression from G1 into S phase. We identified several WT1 binding sites in the cyclin E promoter. We demonstrate that WT1 binds to these sites and that in transient transfection assays WT1 represses the cyclin E promoter. This activity is dependent on the presence of a binding site located downstream of the transcription start site. In intact cells, induction of WT1 expression down-regulates cyclin E protein levels. These results provide the first demonstration that WT1 can directly modulate the expression of a gene involved in cell cycle progression.

Original languageEnglish
Pages (from-to)19627-19632
Number of pages6
JournalJournal of Biological Chemistry
Volume277
Issue number22
DOIs
StatePublished - May 31 2002

Fingerprint

Cyclin E
Genes
Cell Cycle
Cells
S Phase
Tumors
Binding Sites
Wilms' Tumor Genes
Cyclin-Dependent Kinase 2
Transcription Initiation Site
Phase Transition
G1 Phase
Osteosarcoma
Tumor Suppressor Genes
Transfection
Assays
Leukemia
Transcription Factors
Demonstrations
Down-Regulation

ASJC Scopus subject areas

  • Biochemistry

Cite this

Loeb, D. M., Korz, D., Katsnelson, M., Burwell, E. A., Friedman, A. D., & Sukumar, S. (2002). Cyclin E is a target of WT1 transcriptional repression. Journal of Biological Chemistry, 277(22), 19627-19632. https://doi.org/10.1074/jbc.M201336200

Cyclin E is a target of WT1 transcriptional repression. / Loeb, David M.; Korz, Dorian; Katsnelson, Michael; Burwell, Emily A.; Friedman, Alan D.; Sukumar, Saraswati.

In: Journal of Biological Chemistry, Vol. 277, No. 22, 31.05.2002, p. 19627-19632.

Research output: Contribution to journalArticle

Loeb, DM, Korz, D, Katsnelson, M, Burwell, EA, Friedman, AD & Sukumar, S 2002, 'Cyclin E is a target of WT1 transcriptional repression', Journal of Biological Chemistry, vol. 277, no. 22, pp. 19627-19632. https://doi.org/10.1074/jbc.M201336200
Loeb DM, Korz D, Katsnelson M, Burwell EA, Friedman AD, Sukumar S. Cyclin E is a target of WT1 transcriptional repression. Journal of Biological Chemistry. 2002 May 31;277(22):19627-19632. https://doi.org/10.1074/jbc.M201336200
Loeb, David M. ; Korz, Dorian ; Katsnelson, Michael ; Burwell, Emily A. ; Friedman, Alan D. ; Sukumar, Saraswati. / Cyclin E is a target of WT1 transcriptional repression. In: Journal of Biological Chemistry. 2002 ; Vol. 277, No. 22. pp. 19627-19632.
@article{bdd6aa3211564236a5dd9454d3733f33,
title = "Cyclin E is a target of WT1 transcriptional repression",
abstract = "WT1 was originally identified as a Wilms' tumor suppressor gene, but it may have oncogenic potential in leukemia and in some solid tumors. WT1 is a transcription factor that has been implicated in the regulation of target genes related to apoptosis, genitourinary differentiation, and cell cycle progression. Because induction of WT1 leads indirectly to increased p21 expression in osteosarcoma cells, we investigated the possibility that other genes involved in the G1/S phase transition might also be WT1 targets. Cyclin E plays a crucial role in the cell cycle by activating cyclin-dependent kinase 2, which phosphorylates Rb, leading to progression from G1 into S phase. We identified several WT1 binding sites in the cyclin E promoter. We demonstrate that WT1 binds to these sites and that in transient transfection assays WT1 represses the cyclin E promoter. This activity is dependent on the presence of a binding site located downstream of the transcription start site. In intact cells, induction of WT1 expression down-regulates cyclin E protein levels. These results provide the first demonstration that WT1 can directly modulate the expression of a gene involved in cell cycle progression.",
author = "Loeb, {David M.} and Dorian Korz and Michael Katsnelson and Burwell, {Emily A.} and Friedman, {Alan D.} and Saraswati Sukumar",
year = "2002",
month = "5",
day = "31",
doi = "10.1074/jbc.M201336200",
language = "English",
volume = "277",
pages = "19627--19632",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "22",

}

TY - JOUR

T1 - Cyclin E is a target of WT1 transcriptional repression

AU - Loeb, David M.

AU - Korz, Dorian

AU - Katsnelson, Michael

AU - Burwell, Emily A.

AU - Friedman, Alan D.

AU - Sukumar, Saraswati

PY - 2002/5/31

Y1 - 2002/5/31

N2 - WT1 was originally identified as a Wilms' tumor suppressor gene, but it may have oncogenic potential in leukemia and in some solid tumors. WT1 is a transcription factor that has been implicated in the regulation of target genes related to apoptosis, genitourinary differentiation, and cell cycle progression. Because induction of WT1 leads indirectly to increased p21 expression in osteosarcoma cells, we investigated the possibility that other genes involved in the G1/S phase transition might also be WT1 targets. Cyclin E plays a crucial role in the cell cycle by activating cyclin-dependent kinase 2, which phosphorylates Rb, leading to progression from G1 into S phase. We identified several WT1 binding sites in the cyclin E promoter. We demonstrate that WT1 binds to these sites and that in transient transfection assays WT1 represses the cyclin E promoter. This activity is dependent on the presence of a binding site located downstream of the transcription start site. In intact cells, induction of WT1 expression down-regulates cyclin E protein levels. These results provide the first demonstration that WT1 can directly modulate the expression of a gene involved in cell cycle progression.

AB - WT1 was originally identified as a Wilms' tumor suppressor gene, but it may have oncogenic potential in leukemia and in some solid tumors. WT1 is a transcription factor that has been implicated in the regulation of target genes related to apoptosis, genitourinary differentiation, and cell cycle progression. Because induction of WT1 leads indirectly to increased p21 expression in osteosarcoma cells, we investigated the possibility that other genes involved in the G1/S phase transition might also be WT1 targets. Cyclin E plays a crucial role in the cell cycle by activating cyclin-dependent kinase 2, which phosphorylates Rb, leading to progression from G1 into S phase. We identified several WT1 binding sites in the cyclin E promoter. We demonstrate that WT1 binds to these sites and that in transient transfection assays WT1 represses the cyclin E promoter. This activity is dependent on the presence of a binding site located downstream of the transcription start site. In intact cells, induction of WT1 expression down-regulates cyclin E protein levels. These results provide the first demonstration that WT1 can directly modulate the expression of a gene involved in cell cycle progression.

UR - http://www.scopus.com/inward/record.url?scp=0037205498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037205498&partnerID=8YFLogxK

U2 - 10.1074/jbc.M201336200

DO - 10.1074/jbc.M201336200

M3 - Article

VL - 277

SP - 19627

EP - 19632

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 22

ER -